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conformality. Dose statistics, estimated delivery time and 
results of dose verification using the Delta(4) (ScandiDos, 
Sweden) were evaluated.  
Results: The treatment plans fulfilled the dose prescription 
except when PTVb was lying adjacent to the spinal cord. In 
these cases, plan quality was strongly influenced by the 
spinal cord constraint. PTVe conformality was found to be 
suboptimal due to the steep 18-8 Gy gradient. The delivery 
time of the plans ranged between 7-9 min. Measured dose 
distributions showed high agreement with calculated ones, 
with more than 99% of the area within the region of interest 
fulfilling the acceptance criterion. 
 
 
 
Conclusions: The required plan quality and accuracy in dose 
delivery could be obtained using the differential dosing 
approach for spinal SBRT. 
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Purpose/Objective: Simple low conformity lateral opposing 
radiation beams with limited sparing to proximal organs-at-
risk (OARs) were widely adopted in the past for treating 
palliative whole brain radiation therapy (WBRT). Crucial OARs 
located at skull base used to sacrifice with significant 
radiation dose inevitably. More conformal radiation 
treatments, like helical tomotherapy (HT) and volumetric 
modulated arc therapy (VMAT), are becoming more accepted 
to treat WBRT. These techniques allow not only conformal 
dose to the whole brain but also simultaneous integrated 
boost (SIB) doses to dedicated metastases for superior 
disease control and symptom relief. This study aimed to 
investigate any potential advantages in cochleae and eyes 
sparing between HT and non-coplanar VMAT. 
Materials and Methods: Treatment planning computed 
tomography (CT) scans of 15 brain metastasis patients who 
had received palliative dose WBRTs with SIBs to the 
metastases in the department were recruited. Each patient 
was re-planned with HT and non-coplanar VMAT for 
dosimetric comparison. Departmental routine optimal 
settings with fan beam thickness of 2.5cm and pitch value of 
0.287 were used in all HT plans. One coplanar full arc plus 
two non-coplanar half arcs modulating by Varian Millennium 
120 MLCs were used in all VMAT plans. The two non-coplanar 
half arcs were arranged at 60 degrees offset to each other 
and to the coplanar full arc to cover the cranial hemisphere. 
All target volumes were optimized according to original 
prescriptions. The median whole brain dose was 30Gy (range 
25-40Gy) and the median SIB dose was 35Gy (range 30-45Gy). 
The mean SIB volume was 26.7±30.4cc consisting 1.7±1.8% of 
the whole brain volume 1481.8±161.1cc. Radiation doses to 
cochleae and eyes were studied by comparing their maximum 
doses (Dmax) and mean doses (Dmean). The dose results from 
the two techniques were tested statistically by paired t-test 
considering significant level of p-value <0.05. 
Results: The dose results are listed in Table 1. Non-coplanar 
VMAT significantly achieved lower Dmax and Dmean to both 
cochleae than HT (all p<0.001). Radiation doses to both eyes 
were slightly higher in non-coplanar VMAT than in HT but 
could not be shown statistically significant (all p>0.05). 
However, the Dmax and Dmean to both lens were significantly 
higher in non-coplanar VMAT than in HT (p<0.01 and p<0.001, 
respectively). 
Conclusions: Non-coplanar VMAT is superior to HT in sparing 
cochleae which are relatively small and highly proximal to 
target volumes. There is no significant dose difference in 
eyes sparing for both techniques. Non-coplanar VMAT is 
preferred to treat WBRT with SIB if slight increase in lens 
doses is not a concern. 
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Purpose/Objective: This study investigated the potential 
dosimetric benefit of intensity modulated proton therapy 
(IMPT) over rotational intensity-modulated radiotherapy plans 
for nasopharyngeal carcinoma (NPC) patients. Furthermore, 
their robustness to certain anatomical changes was 
examined. 
Materials and Methods: Ten NPC patients planned using 
VMAT (Monaco), TomoTherapy (TomoHD) and IMPT (XiO). All 
patients were planned to receive 65, 60 and 54 Gy in 30 
fractions to the PTVs of primary, intermediate risk and low 
risk nodal regions, respectively. Plans were compared by 
analysing PTV coverage, mean and maximum doses to normal 
structures. Significance testing between techniques was 
performed using the Wilcoxon signed-rank test. 
For robustness comparison between IMPT and VMAT plans, 
each planning CT was artificially modified to simulate (i) 
partial nasal cavity filling and (ii) weight loss (using a 
commercial simulation software, ImSimQA). Dose 
distributions were re-calculated on each artificial CT as 
quality assurance procedure to retaining exactly the same 
parameters and compared against the original dose 
distributions to reveal the dosimetric consequences of each 
anatomical change for the two treatment options. 
Results: All modalities were able to produce plans that would 
